Concepedia

Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer

John R. Eckardt, Dimitri L. Bentsion, Oleg Lipatov, I. S. Polyakov, Frederick R. MacKintosh, David A. Karlin, Gizelle Baker, Hazel B. Breitz

Journal of Clinical Oncology · 2009 · 91 citations · 23 references

DOIFull text

Open access

Abstract

Picoplatin demonstrated clinical efficacy in platinum-refractory SCLC. The major toxicity was hematologic. These results warrant further evaluation in this patient population.

References

23

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +17

Cancer Statistics, 2005

Ahmedin Jemal, Thomas S. Murray, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2005 · 5.5K citations · Full text

, , +16

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Joachim von Pawel, Joan H. Schiller, Frances A. Shepherd et al. · Journal of Clinical Oncology · 1999 · 943 citations

Non-Small Cell Lung Cancer

Elsevier eBooks · 2016 · 859 citations

, , +4

Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer

Mary O’Brien, Tudor–Eliade Ciuleanu, H. Tsekov et al. · Journal of Clinical Oncology · 2006 · 628 citations · Full text